Mantra Pharma Introduces the First Generic Alternative to CLAVULIN® (GSK) in Canada
BROSSARD, QC, December 19, 2022 - Following an increase in cases of respiratory viruses, Canada is currently experiencing supply issues...
Mantra Pharma solidifies its position in the Canadian industry by launching M-Amoxi Clav
Quebec pharmaceutical company Mantra Pharma is pleased to announce the approval of the all-new M-Amoxi Clav (400 mg/57 mg per...
Expansion continues with the launch of 6 products, including M-Apixaban
Since the beginning of 2022, Mantra Pharma has launched several new products, planning to offer no less than six new...
Mantra Solutions launches its continuing education program
Over the last 18 months of the pandemic, many aspects of our lives were completely disrupted, and professional training is...
Mantra Pharma opens its new distribution centre
It is with great pride that Mantra Pharma's Lévis team opened its new warehouse and business location The building already...